Enriching Life Food and Companionship Investor Overview | May 2025 Notices and Disclaimers Forward-Looking Statements. This presentation contains forward-looking statements within the meaning of the federal securities laws, including, without limitation, statements concerning product launches and revenue from such products, our 2025 full year, long-term expectations, our expectations regarding debt levels, and expectations regarding our industry and our operations, performance and financial condition, and i ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? Dev ...

Core Viewpoint - Hims & Hers Health, Inc. has agreed to acquire ZAVA, a European digital health platform, with the deal expected to close in the second half of 2025, funded entirely in cash from the company's balance sheet [1]. Group 1: Acquisition Details - The acquisition will enhance Hims & Hers' presence in the UK and mark its entry into Germany, France, and Ireland, with plans for further market expansion [1][2]. - The deal is anticipated to be accretive by 2026, introducing a personalized dimension of digital health services across various health sectors [4]. Group 2: Market Impact - ZAVA serves over 1.3 million active customers and delivered nearly 2.3 million consultations in 2024 across the UK, Germany, France, and Ireland [3]. - The weight loss opportunity in ZAVA's existing markets is estimated to expand Hims & Hers' Total Addressable Market by $52.1 billion [6]. Group 3: Analyst Insights - Analysts view the acquisition positively, noting that Hims & Hers' existing solutions are well-suited for similar demographics in Europe, indicating potential for durable growth in international markets [5]. - Needham analysts have raised the price forecast for Hims & Hers stock from $61 to $65, estimating ZAVA's annual revenues to be around $100 million [5].